Skip to content

Comparison of ciprofol-based and propofol-based total intravenous anesthesia on post-operative recovery quality in patients undergoing hysteroscopic surgery

Comparison of ciprofol-based and propofol-based total intravenous anesthesia on post-operative recovery quality in patients undergoing hysteroscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095274
Enrollment
Unknown
Registered
2025-01-04
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological disease

Interventions

The ciprofol group:A single induction injection of 0.4 mg/kg, followed by an initial rate of 0.8 mg/kg/h for maintenance. The infusion rates of ciprofol adjusted to maintain a BIS of 40–60.
The propofol group:A single induction injection of 2.0 mg/kg, followed by an initial rate of 5.0 mg/kg/h for maintenance. The infusion rates of propofol adjusted to maintain a BIS of 40–60.

Sponsors

The First Affiliated Hospital, University of South China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. aged 18–60 years; 2. classified with an American Society of Anesthesiologists (ASA) physical status of I–II; 3. scheduled for hysteroscopic surgery; 4. Able to understand the trial protocol and questionnaire content, with the patient or their legal representative signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic alcoholism; 2. pregnant or breastfeeding patients; 3. history of allergy to benzodiazepines, opioids, propofol, or any sedative opioids; 4. uncontrolled hypertension; 5. severe heart, lung, liver, or kidney dysfunction; 6. psychiatric or neurological disorders were excluded. 7. Patients who are unable to communicate due to language barriers or other reasons.

Design outcomes

Primary

MeasureTime frame
QoR-15 score ;

Secondary

MeasureTime frame
Hemodynamic data ;Injection pain;

Countries

China

Contacts

Public ContactHuan Yang

The First Affiliated Hospital, University of South China

yh1587906@163.com+86 133 0734 7268

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026